Core Insights - Syra Health Corp. has secured a six-month contract worth $135,000 with a Midwest university to create virtual training modules focused on behavioral health [1][2] - The training modules will provide healthcare professionals with essential skills to tackle behavioral health issues, featuring up to 60 minutes of interactive content [2] - The total potential value of Syra Health's training agreements is $4.9 million over the next four years, with options for two one-year renewals for both the university and Indiana FSSA contracts [4] Company Overview - Syra Health is a healthcare technology company dedicated to improving health in critical areas such as mental health, population health, and the healthcare workforce [5] - The company emphasizes prevention, access, and affordability in its innovative services and technology [5] - Syra Health aims to empower healthcare professionals through evidence-based training to foster meaningful change in the healthcare sector [4]

Core Insights - Syra Health Corp. has been awarded a healthcare workforce contract by the Washington D.C. government, valued at up to $1 million, to provide healthcare services to students [1][2] - The Indiana Family and Social Services Administration's NeuroDiagnostic Institute has increased its existing contract with Syra Health by $1.2 million, raising the total contract value to $18.7 million [1][3] Contract Details - The Washington D.C. contract involves deploying registered nurses, licensed practical nurses, and certified nursing assistants to ensure the safety and well-being of students, with a focus on compliance with D.C. regulations and timely care delivery [2] - The one-year agreement with Washington D.C. includes options for multiple extensions, indicating potential for future growth [2] Company Commitment - Syra Health emphasizes its commitment to improving health outcomes through tailored services that address staffing shortages and ensure continuity of care [4] - The company has established a long-term partnership with the NeuroDiagnostic Institute, which has been ongoing since 2021, highlighting its dedication to supporting complex neuropsychiatric care [4][3] Company Overview - Syra Health is a healthcare technology company focused on critical areas such as behavioral and mental health, population health, and the healthcare workforce, aiming to enhance prevention, access, and affordability in healthcare [5]

Core Insights - Syra Health Corp. has launched its mental health app, Syrenity, aimed at addressing mental health challenges such as stress, anxiety, and depression, targeting the growing digital mental health market [2][3] - The global mental health app market is projected to grow from $6 billion in 2023 to over $30 billion by 2033, driven by increased awareness and demand for accessible mental health solutions [3] - Syrenity utilizes artificial intelligence to provide a personalized user experience, featuring a 24/7 AI-powered companion named Echo, which supports users in managing their mental health [4] Company Overview - Syra Health is a healthcare technology company focused on behavioral and mental health, digital health, and population health, providing innovative services and technology products [9] - The company aims to make mental health care accessible to everyone and is committed to delivering effective and scalable mental health support [3][9] Product Features - Syrenity offers a comprehensive baseline assessment and uses sophisticated algorithms to generate risk scores for tailored interventions [5] - The app combines education with practical exercises, providing real-time reporting and AI-generated clinical summaries to guide users [6] - Syrenity is HIPAA-compliant, ensuring user confidentiality through advanced encryption and strict protocols [6] Market Strategy - Syra Health plans to expand Syrenity's reach to lower-to-middle-income countries, addressing high unmet mental health needs and diversifying revenue streams [8]

Core Insights - Syra Health Corp. is participating in the Noble Financial Capital Markets 20th Annual Equity Conference, known as NobleCon20, on December 3-4, 2024, in Boca Raton, Florida [1] - The CEO, Dr. Deepika Vuppalanchi, will present the company's healthcare solutions aimed at addressing mental health crises, chronic conditions, and child welfare challenges, emphasizing improved patient outcomes and public health advancements [2][3] - The company is experiencing strong revenue growth and is well-positioned to meet the increasing demand for its innovative healthcare solutions [4] Company Overview - Syra Health is a healthcare technology company focused on behavioral and mental health, digital health, and population health, providing innovative services and technology products [5] - The company's offerings prioritize prevention, improved access, and affordable care, catering to payers, providers, life sciences organizations, academic institutions, and government entities [5]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, $0.001 par value SYRA The Nasdaq Stock Market LLC FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ ...

Exhibit 99.1 Syra Health Delivers Third Quarter 2024 Financial Results Achieved Net Revenue of $2.3 million, ~42% Growth Over the Prior Year Quarter Gross Margins Increased Following Shift in Operational Strategy Net Loss Narrowed to $417,535 ($0.06 per share), a Significant Improvement from the $1.39 million ($0.21 per share) Net Loss in Q2 of 2024 Aiming to Attain Profitability in 2025 through Targeted Revenue Growth and Cost-Ef iciency Measures Conference call will be held today, Tuesday, October 29 at 9 ...

Achieved Net Revenue of $2.3 million, ~42% Growth Over the Prior Year QuarterGross Margins Increased Following Shift in Operational StrategyNet Loss Narrowed to $417,535 ($0.06 per share), a Significant Improvement from the $1.39 million ($0.21 per share) Net Loss in Q2 of 2024Aiming to Attain Profitability in 2025 through Targeted Revenue Growth and Cost-Efficiency MeasuresConference call will be held today, Tuesday, October 29th at 9:00 AM ETCARMEL, Ind., Oct. 29, 2024 /PRNewswire/ -- Syra Health Corp. (N ...

Conference call will be held on Tuesday, October 29 at 9:00 AM ETCARMEL, Ind., Oct. 22, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will report financial results for the three months ended September 30, 2024, on Tuesday, October 29, 2024, before the market opens. The Company has scheduled a conference call that same day, October 29, at 9:00 a.m. ET, t ...

CARMEL, Ind., Oct. 9, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today more details about the award of three new healthcare workforce contracts: one in Florida, one in Kansas, and one in Delaware. In Florida, Syra Health has been awarded a contract to supply psychologists and school counselors to the St. John's County School District in St. Augustine. This effort u ...

CARMEL, Ind., Oct. 1, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, is celebrating its first anniversary as a publicly traded company and highlighting its many successes. This milestone not only marks the Company's growth but also reflects its unwavering commitment to transforming healthcare service. As the Company highlights significant achievements over the past year, it rema ...